Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors.
Ishida H, Isami S, Matsumura T, Umehara H, Yamashita Y, Kajita J, Fuse E, Kiyoi H, Naoe T, Akinaga S, Shiotsu Y, Arai H.
Ishida H, et al. Among authors: isami s.
Bioorg Med Chem Lett. 2008 Oct 15;18(20):5472-7. doi: 10.1016/j.bmcl.2008.09.031. Epub 2008 Sep 11.
Bioorg Med Chem Lett. 2008.
PMID: 18835166